Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Olefin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent CN115160202B enables high-yield Carboprost Tromethamine production. Optimized for cost reduction and supply chain reliability in pharmaceutical intermediates.
Patent CN114195687A discloses a novel Pd-catalyzed synthesis of beta-chloro tetra-substituted alkenyl sulfones, offering high selectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN106279274B enables efficient beta-carbonyl phosphonate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN116640077B reveals metal-free synthesis of 1,1-diseleno olefins. Offers cost reduction and supply chain reliability for high-purity organoselenium intermediates.
Patent CN110172022A reveals a green organophosphorus catalyzed difluoroalkylation method. Discover cost-effective solutions for fluorine material manufacturing and supply chain optimization.
Patent CN101139274B reveals a breakthrough Coenzyme Q10 synthesis using Grubbs catalyst. Discover cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN104629716B reveals high efficiency OLED materials with simplified synthesis. Achieve significant cost reduction and supply chain reliability for display manufacturing.
Patent CN116284100A details a Cu-catalyzed decarboxylative silylation. Offers high E-selectivity and cost efficiency for pharma intermediates.
Patent CN106995373B reveals a one-pot synthesis method using ammonium iodide. This breakthrough offers significant supply chain stability and cost reduction advantages.
Novel electrochemical method replaces gold catalysts for trans-olefin production. High purity, room temperature process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113861086A details a novel Pd-catalyzed route for sulfur-containing diarylamine butyramides, offering mild conditions and simplified purification for pharmaceutical supply chains.
Patent CN109776324B reveals a novel photocatalytic route for homoallyltrifluoromethyl compounds, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Novel catalyst-free synthesis of quaternary carbon center compounds offering high purity and scalable production for pharmaceutical applications.
Novel metal-free electrocatalytic route for 1,4-dicarbonyl-Z olefins. High purity, green synthesis, scalable for pharma intermediates.
Patent CN109574938B reveals a novel synthesis route for Rosuvastatin Sodium featuring mild conditions, high atom economy, and superior stereoselectivity for industrial scale-up.
Patent CN102030779A reveals a safer TiCl4-based route for AMPPD, offering significant cost reduction and scalability for diagnostic reagent manufacturing.
Patent CN110563531A details a copper-catalyzed photocatalytic method for synthesizing 1,2-disubstituted olefins with high stereoselectivity and mild conditions for supply chain optimization.
Patent CN118307476A reveals a novel nickel-catalyzed synthesis for tetra-substituted olefins using isoprene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112299945A reveals a novel FeCl3-catalyzed method for alkyl olefin synthesis using DMSO. This breakthrough offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.